PATENT CLAIM ANALYSIS

Application Number: 15767609
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "206100"]

Abstract:
The disclosure relates to influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Claim (Index 12):
The vaccine of any one of  claims 1 - 11 , wherein the at least one antigenic polypeptide has an amino acid sequence that has 90%-99% identity to an amino acid sequence of SEQ ID NO: 1-444, 458, 460, 462-479 and wherein the antigenic polypeptide or immunogenic fragment thereof has membrane fusion activity, attaches to cell receptors, causes fusion of viral and cellular membranes, and/or is responsible for binding of the virus to a cell being infected.

Metadata:
- Claim Count in Document: 92.0
- Percentile: 91.0
- Lexical Diversity: 1.17391
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15674599', '15091123', '15674591', '15674585', '14701065']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7908601713310346
- 35 USC 102 Novelty (BERT): 0.559617416235364
- Combined Prediction Score: 0.7677358958214675
- Mean Citation Score: 431.615348
- Max Citation Score: 460.40488
- Similarity Product: 320.9485362047577

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test